Mithra’s revenue was impacted by weaker-than-expected Estelle sales in 2021 in the USA. Excess inventory limited H1-2022 orders. Estelle nevertheless represents 68% of turnover (3.7 ME in sales and 4 ME in licensing). The credits dominated by Myring record 2.4 ME…
This stock market news is for subscribers only Privileges
Test our stock market advice for €1, without obligation
